Loading university
Stephen L Buchwald — Professor Stephen L Buchwald's lab at MIT focuses on designing new chemical methods for creating complex organic molecules, which is vital for developing new drugs and therapies. The lab specializes in metal-catalyzed reactions, particularly using palladium and copper, to forge important chemical bonds that are often used in pharmaceuticals. Their work enhances the ability to synthesize important compounds more efficiently and safely, contributing significantly to advancements in medicine and human health.
Matthew G. Vander Heiden — Dr. Matthew G. Vander Heiden's lab focuses on understanding how cancer cells alter their metabolism to support rapid growth and proliferation. By studying the unique metabolic requirements of different cancer types, the lab aims to discover how these processes can be targeted for cancer therapy. The research combines advanced techniques in biochemistry and mouse models to explore the limitations and variations in nutrient usage by cancer cells, providing insights that could lead to new treatments.
Ron Weiss — Ron Weiss's lab focuses on using synthetic biology to develop innovative therapeutic approaches for cancer treatment and organoid engineering. The lab is particularly interested in creating engineered RNA-based therapies that can enhance the immune response against tumors, as well as genetically programming stem cells to produce pancreatic organoids with controlled cell populations. Their work aims to improve cancer treatments and advance organoid technology for developmental biology studies.
Daniel G Anderson — Professor Daniel G. Anderson's research lab at MIT focuses on developing innovative mRNA vaccines for HIV. By combining cutting-edge computational design with biomedical engineering, the lab aims to create vaccines that can elicit a strong immune response, producing broadly neutralizing antibodies that can adapt to various strains of the virus. The lab's work is crucial for addressing the ongoing challenges in creating effective HIV vaccines, with the potential to significantly impact public health.
Xuanhe Zhao — Professor Xuanhe Zhao's lab at MIT focuses on developing innovative biomedical devices to improve patient safety during heart surgery. One of their current projects involves creating an electrically conductive bioadhesive device that integrates with heart tissue without causing trauma or inflammation during placement or removal. This research aims to enhance the effectiveness of temporary cardiac pacing and reduce the risk of complications for patients undergoing cardiac surgery.
Mark F Bear — Professor Mark F. Bear's lab at MIT focuses on understanding visual processing and memory in the brain, especially relating to conditions like amblyopia. The research explores how visual experiences shape the brain's neural circuits, aiming to develop new treatments for visual disorders. By studying the molecular and cellular mechanisms behind synaptic changes, the lab addresses both basic neuroscience and potential clinical applications.
Robert Guy Griffin — Dr. Robert Guy Griffin's lab at MIT focuses on understanding the structures of amyloid proteins, which are crucial in diseases like Alzheimer's. The lab uses advanced techniques in nuclear magnetic resonance (NMR) to study how these proteins form and interact, particularly looking at how certain variations can affect their properties and the development of amyloid-related diseases. This research aims to provide atomic-level insights that could lead to new treatments for amyloid-related conditions.
Ronald T Raines — Professor Ronald T. Raines' lab at MIT focuses on innovating protein chemistry to improve drug delivery methods. The research aims to develop new techniques for proteins to cross cellular membranes and target intracellular processes, which can lead to new therapies for serious diseases, including cancer. By modifying proteins chemically, the lab explores their potential therapeutic applications and how they can be harnessed effectively in biomedical research.
Linda G Griffith — Dr. Linda G. Griffith's lab at MIT focuses on using advanced technologies to better understand and treat women's health issues related to the female reproductive system. They develop innovative models that mimic human tissues, specifically the endometrium, to study diseases like endometriosis and polycystic ovary syndrome (PCOS). By combining insights from biology, engineering, and computational analysis, the lab aims to create personalized medicine solutions that improve clinical outcomes for women suffering from these conditions.